Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Millard

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2008
Ultrathin self-assembled fibrin sheetsE Tim O'Brien, Michael R Falvo, Daniel Millard, et al.
Journal of Pharmacological and Toxicological Methods|November 21, 2017
Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessmentDerek Schocken, Jayna Stohlman, Jose Vicente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 5, 2016
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced ArrhythmiasKsenia Blinova, Jayna Stohlman, Jose Vicente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 3, 2018
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot StudyDaniel Millard, Qianyu Dang, Hong Shi, et al.
Cell Reports|September 27, 2018
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential AssessmentKsenia Blinova, Qianyu Dang, Daniel Millard, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2008
Ultrathin self-assembled fibrin sheetsE Tim O'Brien, Michael R Falvo, Daniel Millard, et al.
Journal of Pharmacological and Toxicological Methods|November 21, 2017
Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessmentDerek Schocken, Jayna Stohlman, Jose Vicente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 5, 2016
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced ArrhythmiasKsenia Blinova, Jayna Stohlman, Jose Vicente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 3, 2018
Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot StudyDaniel Millard, Qianyu Dang, Hong Shi, et al.
Cell Reports|September 27, 2018
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential AssessmentKsenia Blinova, Qianyu Dang, Daniel Millard, et al.
Pageof 1